Publikation
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, With or Without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer
Wissenschaftlicher Artikel/Review - 25.08.2021
Jhaveri Komal, De Vita Serena, Crystal Adam, He Wei, Ji Yan, Balbin Alejandro, Sheng Qing, Kundamal Nicole, Huober Jens, Takahashi Shunji, Terret Catherine, Duhoux Francois P, Layman Rachel M, Cresta Sara, Yap Yoon-Sim, Juric Dejan, Curigliano Giuseppe
Jhaveri, Komal
1
0
Juric, Dejan
1
0
Yap, Yoon-Sim
1
0
Cresta, Sara
2
0
Layman, Rachel M
1
0
Duhoux, Francois P
1
0
Terret, Catherine
2
0
Takahashi, Shunji
1
0
Huober, Jens
Chefarzt/ChefärztinBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
298
12
Kundamal, Nicole
1
0
Sheng, Qing
1
0
Balbin, Alejandro
1
0
Ji, Yan
1
0
He, Wei
1
0
Crystal, Adam
1
0
De Vita, Serena
1
0
Curigliano, Giuseppe
3
0